Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 07, 2015 3:48 PM ET

Capital Markets

Company Overview of Frazier Healthcare Ventures

Company Overview

Frazier Healthcare Ventures is a private equity and venture capital firm specializing in growth equity financing; incubation; expansion stage equity; recapitalizations; leveraged recapitalizations; buyouts; spinouts; shareholder liquidity; startups, early stage investments including seed and Series A and B financing rounds; late stage investments including Series C, D, mid venture, middle market, bridge financing, and PIPEs investments; and de novo investments across all stages of a company’s development. It seeks to invest in the biopharmaceutical, pharmaceutical services, biotechnology, life science, healthcare information technology, medical device, specialty distribution, medical produ...

Two Union Square

601 Union Street

Suite 3200

Seattle, WA 98101

United States

Founded in 1991

Phone:

206-621-7200

Fax:

206-621-1848

Key Executives for Frazier Healthcare Ventures

Managing Partner and Founder
Age: 64
Chief Financial Officer and Partner
General Partner and Founding General Partner
Age: 49
Managing General Partner
Age: 45
General Partner
Compensation as of Fiscal Year 2015.

Frazier Healthcare Ventures Key Developments

Tadataka Yamada Re-Joins the Frazier Healthcare to Serve as a Venture Partner on the Life Sciences Team

Frazier Healthcare announced that Tadataka Yamada, Ph.D. has re-joined the firm. He will serve as a Venture Partner on the Life Sciences team, focusing on creating companies as well as providing strategic guidance to existing portfolio companies. He will also serve as a Senior Advisor to the Growth Buyout team, where he will provide advice on opportunities in pharmaceutical services and spin-outs from large healthcare companies, and sit on boards of portfolio companies such as PCI, a large pharmaceutical services company in the Frazier portfolio. Before re-joining Frazier, Dr. Yamada was Chief Medical and Scientific Officer at Takeda Pharmaceuticals in Tokyo, as well as a member of the Board of Directors. In addition to his role at Frazier, Dr. Yamada serves as a member of the board of directors at the Clinton Health Access Initiative and of the Council of the Institute of Medicine of the National Academy of Sciences.

Frazier Healthcare Adds Chris Karkenny to Growth Buyout Team as an Operating Partner

Frazier Healthcare reported that Chris Karkenny has joined Frazier's Growth Buyout team as an Operating Partner. Karkenny will work with the Growth Buyout team in identifying investment opportunities in the healthcare services space and other related healthcare sectors. The company reported that Karkenny has over 25 years of experience managing high growth environments, completing repositioning, restructurings and consolidations, and executing turnarounds to maximize shareholder value in both public and private companies. According to a release, prior to joining Frazier, Karkenny served as Executive Vice President and Chief Financial Officer at Apria Healthcare.

Richard E. Maroun, Esq. Joins Frazier Healthcare as an Operating Executive

Frazier Healthcare announced that Richard E. Maroun, Esq., has joined the firm as an Operating Executive on the Growth Buyout team. Most recently, Mr. Maroun was Senior Vice President and General Counsel of Aptalis Pharma. He has served in numerous senior roles for APP Pharmaceuticals -- as Executive Vice President, Chief Administrative Officer, General Counsel, and Business Development Officer.

Similar Private Companies By Industry

Company Name Region
North Inlet Partners, LLC United States
Novahill Partners, LLC United States
First Clearing, LLC United States
MidAmerica Financial Services, Inc. United States
W M Industries Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 6, 2015
Collegium Pharmaceutical, Inc.
Private Placement
February 13, 2015
Merganser Biotech, Inc.
Private Placement
February 10, 2015
Cidara Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Frazier Healthcare Ventures, please visit www.frazierhealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.